Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 2 · 100%

Neutropenia · People with advanced non‐small cell lung cancer

Gefitinib leads to lower neutropenia compared with chemotherapy (high certainty).

1 finding from 1 review

Gefitinib for advanced non‐small cell lung cancer 2018 · Cochrane Headline outcomes only
RR 0.04 [0.02, 0.06]
4 studies · 1857 participants
High

Febrile neutropenia · People with advanced non‐small cell lung cancer

Gefitinib leads to lower febrile neutropenia compared with chemotherapy (high certainty).

1 finding from 1 review

Gefitinib for advanced non‐small cell lung cancer 2018 · Cochrane Headline outcomes only
RR 0.12 [0.06, 0.23]
3 studies · 1768 participants
High